Progress on the elimination of viral hepatitis in Zimbabwe: A review of the policies, strategies and challenges

J Viral Hepat. 2021 Jul;28(7):994-1002. doi: 10.1111/jvh.13510. Epub 2021 Apr 9.

Abstract

Very few low-income countries have developed national plans to achieve the viral hepatitis elimination targets set in the World Health Organization (WHO) strategy. We reviewed the policy environment, strategies and challenges on the fight against viral hepatitis in Zimbabwe. The review focussed on the Ministry of Health and Child Care (MoHCC) policy documents, strategic plans and reports. We performed key informant interviews to enhance evidence generated from the document review. Twelve documents were reviewed and interviews with 10 key informants were completed. The MoHCC established a technical working group to work towards elimination of viral hepatitis. The technical working group drafted a strategic plan for elimination of viral hepatitis; however, it is still awaiting implementation. Key strategies that are working well include screening of donated blood for transfusion, safe injection practices and hepatitis B virus (HBV) three-dose vaccination. Current challenges in the drive towards elimination of viral hepatitis include poor to non-existent surveillance systems, lack of epidemiological data, absence of the HBV vaccine birth dose and lack of systematic screening and treatment services for viral hepatitis. In conclusion, despite political will demonstrated towards achieving viral hepatitis elimination, substantial investment and work are required to implement the strategic plan and realize significant success.

Keywords: Zimbabwe; hepatitis B virus; hepatitis C virus; viral hepatitis.

Publication types

  • Review

MeSH terms

  • Health Policy
  • Hepatitis B Vaccines
  • Hepatitis B* / epidemiology
  • Hepatitis B* / prevention & control
  • Hepatitis, Viral, Human* / epidemiology
  • Hepatitis, Viral, Human* / prevention & control
  • Humans
  • World Health Organization
  • Zimbabwe / epidemiology

Substances

  • Hepatitis B Vaccines